Search Results 1551-1560 of 14734 for anti-TNF drugs

1. Tocilizumab (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

   By condition, treatment or drug name. Search tips ... Drugs used in chemotherapy, such as ... anti-CD20 monoclonal antibody), as measured from ...

3. Factor Xiii (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Corifact; Tretten. Descriptions. Factor ...

4. Efficacy and Safety of REC-2282 in Participants with Progressive NF2 Mutated Meningiomas (POPLAR-NF2) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... screening. 3. Received an anti- tumor agent for meningioma within 3 ...

5. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) - Mayo Clinic

   ... treatment (including both insulin dependent and non-insulin dependent diabetes mellitus); Current or past use of insulin or any other anti-diabetic medication ...

6. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

   About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

7. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

   ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

8. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

   It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...

9. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-emetics for at least 2 weeks prior to visit ...

10. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    The antibody is used to recognize tumor cells so the anti-cancer drug can kill them. Participation eligibility. Participant eligibility includes age, gender, ...